Drug makers spend 35% of revenue on promotion

Domestic drug firms have still spent a larger proportion of their annual revenue on promotion to boost sales amid worsening profitability due to the government-mandated cuts in drug prices.

Details of drug company spending revealed Thursday show that the country's KOSPI-listed companies on average spend 35 percent of their annual revenue on marketing and hospitality.

A report released by ...